Global Point-of-Care Infectious Disease Diagnostics Market
Overview
Infectious diseases are caused by microorganisms, which are highly contagious. They can be transmitted from one individual to another through contact with infected animals, contaminated food, or water. They can cause a wide variety of illnesses and can lead to serious health problems, such as cancer. Among the most prevalent infectious diseases are the human papillomavirus, the Epstein-Barr virus, and the Hepatitis B and C viruses. Various laboratory tests for these illnesses are available and are used to determine the severity and cause of the infection.
Certain types of viruses cause pathological changes in infected cells. For example, some viruses produce giant cells called syncytial multinucleated giant cells. Similarly, cytoplasmic inclusions in the cells are suggestive of a specific group of viruses, such as cytomegalovirus. Infections with these types of viruses may also be symptomatic. Infectious diseases are common and a doctor can diagnose and treat them by testing the body fluids and blood.
The global point-of-care infectious disease diagnostics market was valued at US$ 1,764.6 million in 2016 and is projected to exhibit a CAGR of 14.5% over the forecast period (2017 – 2025).
𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/63
Global Point-of-Care Infectious Disease Diagnostics Market: Drivers
High prevalence of HIV is expected to propel growth of the global point-of-care infectious disease diagnostics market over the forecast period. For instance, according to the World Health Organization (WHO), an estimated 36.7 million people were suffering from HIV in 2016.
Moreover, development and launch of new products is also expected to propel growth of the global point-of-care infectious disease diagnostics market over the forecast period. For instance, in May 2017, Alere, Inc. launched Malaria Ag P.f, the first-ever rapid diagnostic test, for detection of asymptomatic malaria infection.
Global Point-of-Care Infectious Disease Diagnostics Market: Opportunities
Increasing funding for R&D in infectious diseases is expected to offer lucrative growth opportunities for players in the global point-of-care infectious disease diagnostics market. For instance, in January 2018, University of Glasgow-led project received US$ 1.85 million funding, which is a part of Global Challenges Research Fund (GCRF). This project will develop new tests for parasitic diseases and point-of-care testing in remote locations to help enable rapid diagnosis, and rapid treatment.
Global Point-of-Care Infectious Disease Diagnostics Market: Restraints
Limitations associated with point-of-care testing such as specific steps and timing and different methodologies than laboratory testing, which may provide difference in the test results from laboratory testing may hinder the growth of the global point-of-care infectious disease diagnostics market.
Recent Developments:
Major players operating in the global point-of-care infectious disease diagnostics market are focused on launching new products to expand their product portfolio. For instance, in 2014, Becton Dickinson and Company launched point-of-care system BD FACSPresto for HIV/AIDS patients.
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/63
Covid-19 Impact Analysis
Globally, as of 7:34pm CET, 6 December 2021, there have been 265,194,191 confirmed cases of COVID-19, including 5,254,116 deaths, reported to WHO. As of 6 December 2021, a total of 7,952,750,402 vaccine doses have been administered. Rapid point-of-care tests are capable of operating in any low-resource setting, including at home. The U.S. Food and Drug Administration has authorized POC tests for SARS-CoV-2, including the Abbott ID NOW and Cepheid GeneXpert.
Market Trends
Asia Pacific is expected to witness significant growth in the global point-of-care infectious disease diagnostics market, owing to high prevalence of tuberculosis in the region. For instance, according to the World Health Organization, in 2018, India reported around 2.69 million cases of tuberculosis.
Major players operating in the global point-of-care infectious disease diagnostics market are focused on approval and launch of new products to expand their product portfolio For instance, in July 2017, OraSure Technologies, Inc. announced that its OraQuick HIV Self-Test (HIVST) has been Prequalified by the World Health Organization.
Global Point-of-Care Infectious Disease Diagnostics Market: Competitive Landscape
Major players operating in the global point-of-care infectious disease diagnostics market include, Abbott Laboratories, AccuBioTech Co., Ltd., Alcon Laboratories, Inc., Becton, Dickinson, and Company, Cardinal Health, Inc., Danaher Corporation, Hoffman-La Roche Ltd., and Trinity Biotech Plc.
Global Point-of-Care Infectious Disease Diagnostics Market: Key Developments
Major players operating in the global point-of-care infectious disease diagnostics market are focused on launching new products to expand their product portfolio. For instance, in January 2018, Cepheid received the U.S. Food & Drug Administration clearance and CLIA waiver for Xpert Xpress Flu test.
Similarly, in January 2017, GenePOC, Inc. announced a new phase in its operations after obtaining CE marking for its revogene instrument and its first set of tests for Group B Streptococcus (GBS) and C. difficile.
𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/63
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Market Dynamics
- Global Point of Care Infectious Disease Diagnostics Market, By Technology, 2015 – 2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016 – 2025
- Segment Trends
- Lateral Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Agglutination Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Flow-Through
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Solid Phase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Introduction
- Global Point of Care Infectious Disease Diagnostics Market, By Application, 2015 – 2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016 – 2025
- Segment Trends
- HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Tropical Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Liver Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Inflammatory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Hospital Associated Infections (HAIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Sexual Health Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Introduction
- Global Point of Care Infectious Disease Diagnostics Market, By End User, 2015 – 2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016 – 2025
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Home-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/point-of-care-infectious-disease-diagnostics-market-to-surpass-us-58542-million-threshold-by-2025-globally-119
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837